semaglutide on backorder The Shortage Is Ending: What's Next For Compounded Drugs? Semaglutide shortage ends as FDA

Because of this, switching requires clinical oversight to reduce the risk of side effects and ensure the new treatment is suitable for you

Similar patterns have been observed with tirzepatide, the active ingredient in Zepbound and Mounjaro

CDC data sounds alarm over obesity Data for 2023 from the Centers for Disease Control and Prevention, released this September, found that in 23 states, more than 1 in 3 adults had obesity

This is a direct consequence of slowed gastric emptying and increased gastrointestinal transit time

Patients can adopt skincare routines that include gentle, non-irritating products to soothe the skin

Remember, GLP-1 RAs were designed to treat type 2 diabetes